IL-15 plasmid gene therapy (Tianjin Medical University)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameIL-15 plasmid gene therapy (Tianjin Medical University)
Drug Alias NamepHi2-spIL15-CEA-tatpHi2-spIL15-CMV-tat
ClassificationCell and gene therapy > Gene therapy > Plasmid
Mechanisms of ActionIL-15 release stimulants
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesTianjin Medical University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTianjin Medical University
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A